Amgen: This Industry Leader Remains Undervalued [Forbes]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Forbes
Amgen: This Industry Leader Remains Undervalued Getty In May 2017 Since then, the stock has more than doubled the performance of the S&P 500 (up 17% vs. S&P up 7%) and helped me earn the #1 ranking for stock pickers on SumZero AMGN’s Economic Earnings Remain Strong AMGN has been a profitable and fast-growing company for years, based on any metric. From 2006 to 2016, the company grew GAAP earnings by 10% compounded annually. AMGN’s economic earnings – the true cash flows of the business – grew at an even more impressive 17% compounded annually over that same time. As Figure 1 shows, however, GAAP earnings declined sharply in 2017 even as economic earnings remained strong. Figure 1: AMGN GAAP vs. Economic Earnings Since 2006 AGMN GAAP vs. Economic Earnings New Constructs, LLC GAAP earnings significantly understate the company’s true profitability for 2017 and the trailing twelve months (TTM) period due to a number of non-recurring expenses. Most notably, the company incurred a $6.1 bil
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024 [Yahoo! Finance]Yahoo! Finance
- AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024PR Newswire
- Global Surgical Suture Market Set to Reach US$ 7,170.1 Million by 2034, Fueled by Technological Advancements and Growing Preference for Sutures Over Alternatives | FMI [Yahoo! Finance]Yahoo! Finance
- Amgen: The Giant With An Impressive Pipeline [Seeking Alpha]Seeking Alpha
- AbbVie keeps Humira market share near 100% despite biosimilars: report [Seeking Alpha]Seeking Alpha
AMGN
Earnings
- 2/6/24 - Beat
AMGN
Sec Filings
- 4/10/24 - Form ARS
- 3/20/24 - Form 4
- 3/20/24 - Form 4
- AMGN's page on the SEC website